Abstract
Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with cellular and molecular mechanisms yet to be fully described. Mutations in a number of genes including SOD1 and FUS are associated with familial ALS. Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts of familial ALS patients bearing SOD1+/A272C and FUS+/G1566A mutations, respectively. We further generated gene corrected ALS iPSCs using CRISPR/Cas9 system. Genome-wide RNA sequencing (RNA-seq) analysis of motor neurons derived from SOD1+/A272C and corrected iPSCs revealed 899 aberrant transcripts. Our work may shed light on discovery of early biomarkers and pathways dysregulated in ALS, as well as provide a basis for novel therapeutic strategies to treat ALS.
Original language | English (US) |
---|---|
Pages (from-to) | 365-378 |
Number of pages | 14 |
Journal | Protein and Cell |
Volume | 8 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2017 |
Bibliographical note
Publisher Copyright:© 2017, The Author(s).
Keywords
- ALS
- CRISPR/Cas9
- gene correction
- iPSC disease modeling
ASJC Scopus subject areas
- Biotechnology
- Biochemistry
- Drug Discovery
- Cell Biology